Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk

Yakugaku Zasshi

Volumn 126, Issue 7, 2006, Pages 495-498

  Mishra, Dina Nath ^a   Vijaya Kumar, Sengodan Gurusamy ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Analgesic; Anti inflammatory; Meloxicam; Skimmed milk; Solid dispersion; Ulcerogenic study

Indexed keywords

MELOXICAM;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DISPERSION; DRUG SOLUBILITY; MILK; MOUSE; NONHUMAN; RAT; ULCEROGENESIS;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BIOLOGICAL AVAILABILITY; DOSAGE FORMS; FEMALE; MALE; MICE; MICE, INBRED STRAINS; MILK; RATS; RATS, WISTAR; SOLUBILITY; THIAZINES; THIAZOLES; WATER;

EID: 33745700098     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.495     Document Type: Article

References (17)

1. Engelhardt G., Homma D., Schlegal K., Utzmann R., Schinitzler C., Inflamm. Res., 44, 423-433 (1995).
2. Chiou W. L., J. Pharm. Sci., 66, 989-991 (1977).
3. Craig D. Q. M., Int. J. Pharm., 231, 131-144 (2002).
4. Martin R. M., Biswas P., Mann R. D., Br. J. Clin. Pharmacol., 50, 35-42 (2000).
5. MacDonald T. M., Morant S. V., Goldstein J. L., Burke T. A., Pettitt D., Gut, 52, 35-42 (2003).
6. Sahin N. O., Librowski T., Pol. J. Pharmacol., 55, 261-265 (2003).
7. Leuner C., Dressman J., Eur. J. Pharm. Biopharm., 50, 47-60 (2000).
8. VijayaKumar S. G., Mishra D. N., Yakugaku Zasshi, 126, 93-97 (2006).
9. Koster R., Anderson W., De Beer E. J., Fed. Proc., 18, 412 (1959).
10. Winter C. A., Risley E. A., Nuss G. W., Proc. Soc. Exp. Biol. med. (New York), 111, 544-547 (1962).
11. Nagarsenker M. S., Meshram R. N., Ramprakash G., J. Pharm. Pharmacol., 52, 949-956 (2000).
12. Zerrouk N., Mennini N., Maestrelli F., Chemtob C., Mura P., Eur. J. Pharm. Biopharm., 57, 93-99 (2004).
13. Barzegar-Jalali M., Maleki N., Garjani A., Khandar A. A., Haji-Hosseinloo M., Jabbari R., Dastmalachi S., Drug Dev. Ind. Pharm., 28, 681-686 (2002).
14. Nagarsenker M. S., Joshi M. S., Drug Dev. Ind. Pharm., 31, 169-178 (2005).
15. Topaloglu Y., Yener G., Kavalali G., Acta Pharm. Turcica., 40, 13-16 (1998).
16. Topaloglu Y., Yener G., Toprak N., Acta Pharm. Turcica., 39, 167-170 (1997).
17. Nambu N., Kikuchi K., Kikuchi T., Takahashi Y., Ueda H., Nagai T., Chem. Pharm. Bull., 26, 3609-3612 (1978).